F.D.A. Panel Unanimously Recommends Johnson & Johnson Booster Shots But many panel members said J. & J. recipients might also benefit from the option of a Pfizer-BioNTech or Moderna booster, an action that an F.D.A. official said was possible. https://ift.tt/2XidLiy https://nyti.ms/3eyQv5F

But many panel members said J. & J. recipients might also benefit from the option of a Pfizer-BioNTech or Moderna booster, an action that an F.D.A. official said was possible.

from NYT > Top Stories https://nyti.ms/3FRUaKg
via IFTTT